Serial #79201268
LIVE

Serial Number

79201268

Owner

ADOCIA

Attorney

Beth E. Cooperstein

Filing Date

Oct 10, 2016

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79201268 Trademark

Serial Number: 79201268 • Registration: 5499785

Serial #79201268 is a trademark filed by ADOCIA on October 10, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ADOCIA (10 trademarks)

115 avenue Lacassagne

Entity Type: 99

Trademark Details

Filing Date

October 10, 2016

Registration Date

June 26, 2018

Published for Opposition

April 10, 2018

Cancellation Date

January 10, 2025

Goods & Services

Chemical products intended to be integrated in medicines so as to improve their effectiveness, namely, pharmaceutical excipients sold as an integral component of medicines so as to promote dissemination in a given area of the human body; pharmaceutical excipients, namely, drug delivery agents consisting of chemical compounds that improve delivery of a wide range of pharmaceuticals; pharmaceutical substances for medical use, namely for treatment of diabetes; pharmaceutical and veterinary products, namely for treatment of diabetes

Chemical products for use in science, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes; chemical products for use in the medical and pharmaceutical industries, namely, polymers for the manufacture of pharmaceutical preparations, oligomers for the manufacture of pharmaceutical preparations, small organic compounds being hydro-carbonated compounds used in biotechnology research and the manufacture of pharmaceuticals preparations, molecules comprising carbon, hydrogen and oxygen atoms used in biotechnology research and the manufacture of pharmaceuticals preparations, peptides substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use, polypeptides for in vitro research use and proteins for the manufacture of pharmaceutical preparations for the treatment of diabetes

Medical research; scientific and technological services, namely, scientific analysis, scientific research and development and design and testing of new products for others, clinical research, all in the field of treatment of diabetes

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 5, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 14, 2026 INTS
INVALIDATION PROCESSED
Feb 14, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 10, 2025 INTR
CANCELLED SECTION 71
Jan 10, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 26, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 19, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 28, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 28, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 26, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 26, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 10, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 10, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Apr 6, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 21, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 21, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 21, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 6, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 6, 2017 GNFN
FINAL REFUSAL E-MAILED
Sep 6, 2017 GNFR
FINAL REFUSAL WRITTEN
Sep 6, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2017 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 7, 2017 NREP
REFUSAL PROCESSED BY IB
Mar 11, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 17, 2017 RFCS
REFUSAL PROCESSED BY MPU
Feb 17, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Feb 15, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 14, 2017 MAFR
ASSIGNED TO EXAMINER
Feb 10, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 10, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2017 REPR